首页 | 本学科首页   官方微博 | 高级检索  
     

Ezrin增强子敲除可抑制人食管癌Eca-109细胞的增殖和迁移
引用本文:雷悦,野庆松,卫金岐,李文娜,莫镇涛,张青峰,高书颖. Ezrin增强子敲除可抑制人食管癌Eca-109细胞的增殖和迁移[J]. 中国肿瘤生物治疗杂志, 2019, 26(1): 29-35
作者姓名:雷悦  野庆松  卫金岐  李文娜  莫镇涛  张青峰  高书颖
作者单位:1. 遵义医学院珠海校区 a. 生物化学与分子生物学教研室;b. 珠海市优势学科药理学,广东珠海519041;2. 中山大学附属第五医院消化内科,广东珠海 519000
基金项目:国家自然科学基金资助项目(No. 31360212,No. 81760697,No. 81760723);贵州省科学技术基金(黔科合J 字[2014]2180 号)
摘    要:[摘要] 目的:探讨ezrin 增强子敲除对食管癌Eca-109 细胞ezrin 基因表达、细胞增殖和迁移的影响。方法:将靶向ezrin 增强子上、下游的CRISPR/Cas9 重组质粒共转染食管癌Eca-109 细胞,经嘌呤霉素筛选,获得敲除ezrin 增强子的细胞株Eca-C2。用qPCR和Western blotting 分别检测敲除ezrin 增强子的Eca-C2 细胞中ezrin mRNA和蛋白的表达,用蛋白芯片技术检测MAPK通路相关蛋白的表达,用WST-1 法和细胞划痕愈合实验分别检测ezrin 增强子敲除对Eca-C2 细胞增殖和迁移能力的影响。结果:成功构建稳定敲除ezrin 增强子的食管癌细胞株Eca-C2;与对照细胞相比,ezrin 增强子敲除细胞ezrin mRNA和蛋白的表达水平均明显降低(均P<0.05)。Eca-C2 细胞中17 种被检测的MAPK通路相关蛋白中有9 种(AKT、CREB、GSK3b、MKK6、mTOR、P38、P53、P70S6K和RSK1)表达下调,ezrin 增强子敲除后细胞的增殖和迁移能力受到明显抑制(均P<0.05)。结论:在人食管癌Eca-109 细胞中,敲除ezrin增强子可明显抑制细胞的增殖和迁移。

关 键 词:ezrin增强子;基因敲除;食管癌;Eca-109 细胞;增殖;迁移
收稿时间:2018-07-10
修稿时间:2018-11-12

Ezrin enhancer knockout inhibits the proliferation and migration of human esophageal carcinoma Eca-109 cells
LEI Yue,YE Qingsong,WEI Jinqi,LI Wenn,MO Zhentao,ZHANG Qingfeng and GAO Shuying. Ezrin enhancer knockout inhibits the proliferation and migration of human esophageal carcinoma Eca-109 cells[J]. Chinses Journal of Cancer Biotherapy, 2019, 26(1): 29-35
Authors:LEI Yue  YE Qingsong  WEI Jinqi  LI Wenn  MO Zhentao  ZHANG Qingfeng  GAO Shuying
Affiliation:1a. Department of Biochemistry and Molecular Biology; 1b. Zhuhai Premier-Discipline Enhancement Scheme of Pharmacology, Zhuhai Campus of Zunyi Medical University, Zhuhai 519041, Guangdong, China; 2. Department of Gastroenterology, the Fifth Affiliated Hospital of Sun Yat-sen University,Zhuhai 519000, Guangdong, China
Abstract:[Abstract] Objective: To investigate the effects of ezrin enhancer knockout on ezrin gene expression, cell proliferation and migration of human esophageal carcinoma Eca-109 cells. Methods: The CRISPR/Cas9 recombinant plasmids targeting upstream/downstream of human ezrin enhancer were co-transfected into human esophageal carcinoma Eca-109 cells, and the cell line Eca-C2 with ezrin enhancer knockout was screened by purinomycin. Then the expression levels of ezrin mRNA and protein in Eca-C2 cells were detected by Real-time quantitative PCR (qPCR) and Western blotting, respectively; The expression levels of MAPK-pathway-related proteins were detected by protein array technology; and the effects of ezrin enhancer knockout on the proliferation and migration of Eca-C2 cells were analyzed by WST-1 method and wound-healing assay, respectively. Results: The human esophageal carcinoma cell line Eca-C2 with stable ezrin enhancer knockout was established successfully. Compared with control cells, the mRNA and protein expressions of ezrin in Eca-C2 cells were significantly reduced (all P<0.05). Among the 17 detected MAPK pathway related proteins in Eca-C2 cells, 9 proteins (AKT, CREB, GSK3b, MKK6, mTOR, P38, P53, P70S6K and RSK1) were down-regulated, and the cell proliferation and migration were significantly inhibited (all P<0.05). Conclusion: ezrin enhancer knockout can significantly inhibit the cell proliferation and migration of human esophageal carcinoma Eca-109 cells.
Keywords:ezrin enhancer   gene knockout   esophageal carcinoma   Eca-109 cell   proliferation   migration
点击此处可从《中国肿瘤生物治疗杂志》浏览原始摘要信息
点击此处可从《中国肿瘤生物治疗杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号